抗病毒治疗失败及耐药的应对策略-PPT幻灯片.pptVIP

* ADDITIONAL INFORMATION: (Hogg RS et al. PLoS Med. 2006;3:e356) ARV drugs and the proportion taking the drug: Protease inhibitors: Indinavir – 75.5%; Nelfinavir – 12.1%; Saquinavir – 8.3%; Ritonavir – 3.9% NNRTIs: NVP – 93.8%; EFV – 2.8%; Delavirdine – 3.4% Editor’s summary of the findings: These results provide information about the emergence of drug-resistant HIV during HAART and the possible effects on the long-term survival of patients. In particular, they suggest that clinicians should watch carefully for the emergence of resistance to NNRTIs in their patients – this type of resistance